Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group's clinical trial E3999.
Rapaport F, Seier K, Neelamraju Y, Hassane D, Baslan T, Gildea DT, Haddox S, Lee T, Murdock HM, Sheridan C, Thurmond A, Wang L, Carroll M, Cripe LD, Fernandez H, Mason CE, Paietta E, Roboz GJ, Sun Z, Tallman MS, Zhang Y, Gönen M, Levine R, Melnick AM, Kleppe M, Garrett-Bakelman FE.
Rapaport F, et al. Among authors: cripe ld.
Blood Cancer J. 2022 Sep 23;12(9):137. doi: 10.1038/s41408-022-00736-z.
Blood Cancer J. 2022.
PMID: 36151075
Free PMC article.